Calidi Biotherapeutics, INC Form 4 insider transactions

Wendy Pizarro Campbell, Chief Admin. and Legal Officer of Calidi Biotherapeutics, was granted stock options to purchase 100,000 shares of common stock at an exercise price of $0.195 per share.

Andrew Jackson, CFO of Calidi Biotherapeutics, was granted 300,000 stock options on June 17, 2024, at an exercise price of $0.195.

James A. Schoeneck, a director at Calidi Biotherapeutics, exercised warrants to acquire common stock and new warrants, as part of an inducement offer.

James Schoeneck, a director of Calidi Biotherapeutics, acquired 375,000 shares of common stock and associated warrants through a recent public offering.